Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A revised electronic version of RUCAM for the diagnosis of DILI.
Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, Gonzalez-Jimenez A, Yang Q, Gu J, Andrade RJ, Hoofnagle JH. Hayashi PH, et al. Among authors: hoofnagle jh. Hepatology. 2022 Jul;76(1):18-31. doi: 10.1002/hep.32327. Epub 2022 Mar 22. Hepatology. 2022. PMID: 35014066 Free PMC article.
Drug-induced liver injury network (DILIN).
Hoofnagle JH. Hoofnagle JH. Hepatology. 2004 Oct;40(4):773. doi: 10.1002/hep.20445. Hepatology. 2004. PMID: 15382161 No abstract available.
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C; HALT-C Trial Group. Lok AS, et al. Hepatology. 2009 Jun;49(6):1828-37. doi: 10.1002/hep.22865. Hepatology. 2009. PMID: 19291787 Free PMC article. Clinical Trial.
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR; HALT-C Trial Group. Welzel TM, et al. Hepatology. 2009 Jun;49(6):1847-58. doi: 10.1002/hep.22877. Hepatology. 2009. PMID: 19434718 Free PMC article.
Important elements for the diagnosis of drug-induced liver injury.
Agarwal VK, McHutchison JG, Hoofnagle JH; Drug-Induced Liver Injury Network. Agarwal VK, et al. Among authors: hoofnagle jh. Clin Gastroenterol Hepatol. 2010 May;8(5):463-70. doi: 10.1016/j.cgh.2010.02.008. Epub 2010 Feb 17. Clin Gastroenterol Hepatol. 2010. PMID: 20170750 Free PMC article. Review.
529 results